| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | multivesicular body lumen | 4.40e-05 | 7 | 229 | 3 | GO:0097486 | |
| GeneOntologyCellularComponent | lysosomal lumen | 1.03e-04 | 98 | 229 | 7 | GO:0043202 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 1.04e-04 | 9 | 229 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | postsynaptic membrane | CSMD2 ITGB4 CHRNB2 CHRNG PTPRS MKLN1 ANK2 SYNE1 ITGA8 CBLN1 CELSR3 TIAM1 CSPG5 EPHA4 | 1.62e-04 | 405 | 229 | 14 | GO:0045211 |
| GeneOntologyCellularComponent | late endosome lumen | 2.01e-04 | 11 | 229 | 3 | GO:0031906 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 4.32e-04 | 14 | 229 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | synaptic membrane | CSMD2 ITGB4 CHRNB2 CHRNG PTPRD PTPRS MKLN1 ANK2 SYNE1 L1CAM ITGA8 CBLN1 CELSR3 TIAM1 CSPG5 EPHA4 | 7.36e-04 | 583 | 229 | 16 | GO:0097060 |
| Domain | fn3 | EPHB4 ITGB4 FNDC1 ANOS1 PTPRD PTPRS USH2A CNTN4 COL7A1 L1CAM EPHA2 ROS1 TNXB EPHA4 | 1.04e-08 | 162 | 225 | 14 | PF00041 |
| Domain | LAM_G_DOMAIN | 1.40e-08 | 38 | 225 | 8 | PS50025 | |
| Domain | LamG | 4.78e-08 | 44 | 225 | 8 | SM00282 | |
| Domain | FN3 | EPHB4 ITGB4 FNDC1 ANOS1 PTPRD PTPRS USH2A CNTN4 COL7A1 L1CAM EPHA2 ROS1 TNXB EPHA4 | 5.60e-08 | 185 | 225 | 14 | SM00060 |
| Domain | FN3 | EPHB4 ITGB4 FNDC1 ANOS1 PTPRD PTPRS USH2A CNTN4 COL7A1 L1CAM EPHA2 ROS1 TNXB EPHA4 | 1.39e-07 | 199 | 225 | 14 | PS50853 |
| Domain | - | GAS6 ADGRG4 FAT1 USH2A SHBG LAMA3 LGALS8 CELSR1 CELSR3 CSPG4 | 2.18e-07 | 95 | 225 | 10 | 2.60.120.200 |
| Domain | FN3_dom | EPHB4 ITGB4 FNDC1 ANOS1 PTPRD PTPRS USH2A CNTN4 COL7A1 L1CAM EPHA2 ROS1 TNXB EPHA4 | 2.54e-07 | 209 | 225 | 14 | IPR003961 |
| Domain | Laminin_G_2 | 4.46e-07 | 40 | 225 | 7 | PF02210 | |
| Domain | Laminin_G | 4.47e-07 | 58 | 225 | 8 | IPR001791 | |
| Domain | DUF2012 | 6.84e-06 | 4 | 225 | 3 | PF09430 | |
| Domain | DUF2012 | 6.84e-06 | 4 | 225 | 3 | IPR019008 | |
| Domain | EGF_LAM_2 | 2.71e-05 | 30 | 225 | 5 | PS50027 | |
| Domain | EGF_LAM_1 | 2.71e-05 | 30 | 225 | 5 | PS01248 | |
| Domain | - | 2.78e-05 | 73 | 225 | 7 | 2.60.120.260 | |
| Domain | - | EPHB4 IL18R1 ITGB4 FNDC1 ANOS1 PTPRD NOMO2 PTPRS USH2A KIT CNTN4 FLNA COL7A1 L1CAM PKHD1L1 NOMO1 EPHA2 ROS1 TNXB NOMO3 EPHA4 | 5.51e-05 | 663 | 225 | 21 | 2.60.40.10 |
| Domain | Aspartic_peptidase_N | 5.83e-05 | 7 | 225 | 3 | IPR012848 | |
| Domain | A1_Propeptide | 5.83e-05 | 7 | 225 | 3 | PF07966 | |
| Domain | EGF_Lam | 5.87e-05 | 35 | 225 | 5 | SM00180 | |
| Domain | Laminin_EGF | 5.87e-05 | 35 | 225 | 5 | PF00053 | |
| Domain | ConA-like_dom | GAS6 ITGB4 ADGRG4 FAT1 USH2A SHBG LAMA3 LGALS8 CELSR1 CELSR3 CSPG4 | 7.33e-05 | 219 | 225 | 11 | IPR013320 |
| Domain | EGF-like_CS | EPHB4 RELN GAS6 LAMC3 ITGB4 FAT1 LAMA3 CELSR1 CELSR3 EPHA2 CSPG5 TNXB | 8.10e-05 | 261 | 225 | 12 | IPR013032 |
| Domain | Laminin_EGF | 8.81e-05 | 38 | 225 | 5 | IPR002049 | |
| Domain | Carb-bd-like_fold | 9.24e-05 | 8 | 225 | 3 | IPR013784 | |
| Domain | EGF_2 | EPHB4 RELN GAS6 LAMC3 ITGB4 FAT1 LAMA3 CELSR1 CELSR3 EPHA2 CSPG5 TNXB | 9.35e-05 | 265 | 225 | 12 | PS01186 |
| Domain | Ig-like_fold | EPHB4 IL18R1 ITGB4 FNDC1 ANOS1 PTPRD NOMO2 PTPRS USH2A KIT CNTN4 FLNA COL7A1 L1CAM PKHD1L1 NOMO1 EPHA2 ROS1 TNXB NOMO3 EPHA4 | 1.33e-04 | 706 | 225 | 21 | IPR013783 |
| Domain | Galactose-bd-like | 1.41e-04 | 94 | 225 | 7 | IPR008979 | |
| Domain | ARHGEF5_35 | 1.44e-04 | 2 | 225 | 2 | PF15441 | |
| Domain | ARHGEF5/35_N | 1.44e-04 | 2 | 225 | 2 | IPR029212 | |
| Domain | Aspartic_peptidase_A1 | 1.94e-04 | 10 | 225 | 3 | IPR001461 | |
| Domain | PEPTIDASE_A1 | 1.94e-04 | 10 | 225 | 3 | IPR033121 | |
| Domain | Asp | 1.94e-04 | 10 | 225 | 3 | PF00026 | |
| Domain | PEPTIDASE_A1 | 1.94e-04 | 10 | 225 | 3 | PS51767 | |
| Domain | - | 2.65e-04 | 11 | 225 | 3 | 1.10.730.10 | |
| Domain | Laminin_G_1 | 2.65e-04 | 11 | 225 | 3 | PF00054 | |
| Domain | EGF_1 | RELN GAS6 LAMC3 ITGB4 FAT1 USH2A LAMA3 CELSR1 CELSR3 CSPG5 TNXB | 2.78e-04 | 255 | 225 | 11 | PS00022 |
| Domain | - | 3.50e-04 | 12 | 225 | 3 | 2.40.70.10 | |
| Domain | ASP_PROTEASE | 3.50e-04 | 12 | 225 | 3 | PS00141 | |
| Domain | CarboxyPept_regulatory_dom | 4.51e-04 | 13 | 225 | 3 | IPR014766 | |
| Domain | Aspartic_peptidase_AS | 4.51e-04 | 13 | 225 | 3 | IPR001969 | |
| Domain | - | 4.51e-04 | 13 | 225 | 3 | 2.60.40.1120 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 5.69e-04 | 14 | 225 | 3 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 5.69e-04 | 14 | 225 | 3 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 5.69e-04 | 14 | 225 | 3 | IPR001426 | |
| Domain | EphA2_TM | 5.69e-04 | 14 | 225 | 3 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 5.69e-04 | 14 | 225 | 3 | IPR001090 | |
| Domain | Eph_TM | 5.69e-04 | 14 | 225 | 3 | IPR027936 | |
| Domain | EPH_lbd | 5.69e-04 | 14 | 225 | 3 | SM00615 | |
| Domain | Ephrin_lbd | 5.69e-04 | 14 | 225 | 3 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 5.69e-04 | 14 | 225 | 3 | IPR016257 | |
| Domain | EPH_LBD | 5.69e-04 | 14 | 225 | 3 | PS51550 | |
| Domain | Growth_fac_rcpt_ | 6.17e-04 | 156 | 225 | 8 | IPR009030 | |
| Domain | Tyr_kinase_cat_dom | 6.81e-04 | 88 | 225 | 6 | IPR020635 | |
| Domain | TyrKc | 6.81e-04 | 88 | 225 | 6 | SM00219 | |
| Domain | tRNAsynth_Ia_anticodon-bd | 7.05e-04 | 15 | 225 | 3 | IPR009080 | |
| Domain | GPS | 7.16e-04 | 34 | 225 | 4 | SM00303 | |
| Domain | GPS | 8.01e-04 | 35 | 225 | 4 | PF01825 | |
| Domain | Laminin_N | 8.60e-04 | 16 | 225 | 3 | IPR008211 | |
| Domain | LamNT | 8.60e-04 | 16 | 225 | 3 | SM00136 | |
| Domain | LAMININ_NTER | 8.60e-04 | 16 | 225 | 3 | PS51117 | |
| Domain | Laminin_N | 8.60e-04 | 16 | 225 | 3 | PF00055 | |
| Domain | PTPc | 8.93e-04 | 36 | 225 | 4 | SM00194 | |
| Domain | GPS | 8.93e-04 | 36 | 225 | 4 | PS50221 | |
| Domain | Pkinase_Tyr | 9.68e-04 | 129 | 225 | 7 | PF07714 | |
| Domain | GPS | 9.92e-04 | 37 | 225 | 4 | IPR000203 | |
| Domain | CarboxyPept-like_regulatory | 1.04e-03 | 17 | 225 | 3 | IPR008969 | |
| Domain | Peptidase_aspartic_dom | 1.04e-03 | 17 | 225 | 3 | IPR021109 | |
| Domain | PROTEIN_KINASE_TYR | 1.14e-03 | 97 | 225 | 6 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.14e-03 | 97 | 225 | 6 | IPR008266 | |
| Domain | TYR_PHOSPHATASE_PTP | 1.21e-03 | 39 | 225 | 4 | PS50055 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 1.23e-03 | 18 | 225 | 3 | IPR008930 | |
| Domain | BRO1 | 1.41e-03 | 5 | 225 | 2 | PF03097 | |
| Domain | Cyt_B5_heme-BS | 1.41e-03 | 5 | 225 | 2 | IPR018506 | |
| Domain | BRO1_dom | 1.41e-03 | 5 | 225 | 2 | IPR004328 | |
| Domain | BRO1 | 1.41e-03 | 5 | 225 | 2 | SM01041 | |
| Domain | BRO1 | 1.41e-03 | 5 | 225 | 2 | PS51180 | |
| Domain | - | 1.41e-03 | 5 | 225 | 2 | 1.25.40.280 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.43e-03 | 138 | 225 | 7 | IPR001245 | |
| Domain | PTPase_domain | 1.46e-03 | 41 | 225 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 1.46e-03 | 41 | 225 | 4 | PF00102 | |
| Domain | Ig_E-set | 1.63e-03 | 104 | 225 | 6 | IPR014756 | |
| Domain | Glyco_hydro_31_AS | 2.10e-03 | 6 | 225 | 2 | IPR030458 | |
| Domain | EGF | 2.25e-03 | 235 | 225 | 9 | SM00181 | |
| Domain | Glyco_hydro_31 | 2.92e-03 | 7 | 225 | 2 | IPR000322 | |
| Domain | Glyco_hydro_31 | 2.92e-03 | 7 | 225 | 2 | PF01055 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 2.92e-03 | 7 | 225 | 2 | PS00129 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPHB4 MYO10 LAMC3 ITGB4 PCNX2 FAT1 WIZ EIF4ENIF1 TULP4 PTPRS PKD1 ARHGAP21 FLNA NDST1 SLC37A3 FNTB UBR4 L1CAM CEP192 LRRK1 WDR59 CELSR1 CELSR3 RPAP1 ADAMTS7 CSPG4 USP40 DISP2 TANC1 SPEN PRDM16 | 1.93e-11 | 1105 | 233 | 31 | 35748872 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EPHB4 SELENOT ATP6AP1 MANBA NBPF26 LAMC3 RXYLT1 ITGB4 GPR180 FAT1 GLB1 NOMO2 PTPRS MANEAL UTP20 ARHGAP21 NDST1 COL7A1 DPYSL2 SGSH B3GALNT2 L1CAM RNF213 NOMO1 TGFB1 CELSR1 CELSR3 PPT1 EPHA2 CSPG4 PCDH7 | 1.52e-10 | 1201 | 233 | 31 | 35696571 |
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 7926498 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 9561228 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 21455714 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 19800305 | ||
| Pubmed | Human pepsinogen A (PGA): an informative gene complex located at 11q13. | 2.97e-07 | 3 | 233 | 3 | 1968039 | |
| Pubmed | Family and population studies on the human pepsinogen A multigene family. | 2.97e-07 | 3 | 233 | 3 | 2566575 | |
| Pubmed | Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. | 2.97e-07 | 3 | 233 | 3 | 19890696 | |
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 6774973 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 6300126 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 24004680 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 23034090 | ||
| Pubmed | Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A. | 2.97e-07 | 3 | 233 | 3 | 3554488 | |
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 23521833 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 3017318 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 9855083 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 2478370 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 3815274 | ||
| Pubmed | Pepsinogens: physiology, pharmacology pathophysiology and exercise. | 2.97e-07 | 3 | 233 | 3 | 10675278 | |
| Pubmed | Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11. | 2.97e-07 | 3 | 233 | 3 | 3839486 | |
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 3467902 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 4586732 | ||
| Pubmed | Genomic structure and evolution of the human pepsinogen A multigene family. | 2.97e-07 | 3 | 233 | 3 | 2892778 | |
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 24383519 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 1455184 | ||
| Pubmed | Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach. | 2.97e-07 | 3 | 233 | 3 | 2831884 | |
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 1812762 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 7923573 | ||
| Pubmed | An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse. | 2.97e-07 | 3 | 233 | 3 | 11566730 | |
| Pubmed | The effect of acute and chronic protein loading on urinary pepsinogen A excretion. | 2.97e-07 | 3 | 233 | 3 | 1956484 | |
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 22992016 | ||
| Pubmed | Gastric chief cell-specific transcription of the pepsinogen A gene. | 2.97e-07 | 3 | 233 | 3 | 8504820 | |
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 20428942 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 9525001 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 7886402 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 21547904 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 36011023 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 24170207 | ||
| Pubmed | Relationships between the human pepsinogen DNA and protein polymorphisms. | 2.97e-07 | 3 | 233 | 3 | 3014868 | |
| Pubmed | The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. | 2.97e-07 | 3 | 233 | 3 | 2799289 | |
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 19872561 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 8053437 | ||
| Pubmed | Immunoblot technique to visualise serum pepsinogen A isozymogen patterns. | 2.97e-07 | 3 | 233 | 3 | 2229438 | |
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 25314140 | ||
| Pubmed | Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. | 2.97e-07 | 3 | 233 | 3 | 8244094 | |
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 21407214 | ||
| Pubmed | Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels. | 2.97e-07 | 3 | 233 | 3 | 22304859 | |
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 8038355 | ||
| Pubmed | Human pepsinogen A isozymogen patterns in serum and gastric mucosa. | 2.97e-07 | 3 | 233 | 3 | 2227273 | |
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 24125879 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 8751234 | ||
| Pubmed | Serum pepsinogen test for early detection of gastric cancer in a European country. | 2.97e-07 | 3 | 233 | 3 | 21989121 | |
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 9797498 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 3780036 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 2901984 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 2032552 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 9061458 | ||
| Pubmed | Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis. | 2.97e-07 | 3 | 233 | 3 | 12588289 | |
| Pubmed | Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA. | 2.97e-07 | 3 | 233 | 3 | 23897256 | |
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 8540382 | ||
| Pubmed | The role of serum pepsinogen in the detection of gastric cancer. | 2.97e-07 | 3 | 233 | 3 | 20981206 | |
| Pubmed | Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry. | 2.97e-07 | 3 | 233 | 3 | 21970995 | |
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 2.97e-07 | 3 | 233 | 3 | 25576386 | |
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 17379991 | ||
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 3.42e-07 | 67 | 233 | 7 | 21875946 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 1.18e-06 | 4 | 233 | 3 | 31833031 | |
| Pubmed | Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression. | 1.18e-06 | 4 | 233 | 3 | 17136346 | |
| Pubmed | 1.18e-06 | 4 | 233 | 3 | 9267806 | ||
| Pubmed | Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes. | 1.18e-06 | 4 | 233 | 3 | 23047493 | |
| Pubmed | Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. | 1.18e-06 | 4 | 233 | 3 | 11915945 | |
| Pubmed | 1.18e-06 | 4 | 233 | 3 | 8322031 | ||
| Pubmed | 1.18e-06 | 4 | 233 | 3 | 12698190 | ||
| Pubmed | EIF4ENIF1 FNIP1 ASCC3 ARHGAP21 ARHGEF12 CEP192 SNX29 ARFGEF3 EPHA2 TANC1 | 1.65e-06 | 209 | 233 | 10 | 36779422 | |
| Pubmed | 2.94e-06 | 5 | 233 | 3 | 21935409 | ||
| Pubmed | 2.94e-06 | 5 | 233 | 3 | 22066020 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | A2M EPHB4 GAS6 EPS8L1 PGA5 PTPRD GLB1 PTPRS LYPLA1 PGA3 GOT1 FLNA MGAM PGA4 SGSH SHBG LAMA3 CR1 BROX PPT1 CSPG4 TNXB | 3.65e-06 | 1070 | 233 | 22 | 23533145 |
| Pubmed | 3.81e-06 | 62 | 233 | 6 | 15862967 | ||
| Pubmed | RIPOR2 MYO10 FAM91A1 FNIP1 ARHGAP21 SYNE1 FRMPD1 ARHGEF12 CEP192 ARFGEF3 RPAP1 DISP2 SPEN | 4.27e-06 | 407 | 233 | 13 | 12693553 | |
| Pubmed | A2M ATP6AP1 MANBA MARS1 FBXO4 GLB1 NOMO2 PTPRS SGSH B3GALNT2 L1CAM NOMO1 TGFB1 PPT1 EIF3B NOMO3 | 4.50e-06 | 613 | 233 | 16 | 22268729 | |
| Pubmed | Receptor protein tyrosine phosphatases are novel components of a polycystin complex. | 5.85e-06 | 6 | 233 | 3 | 21126580 | |
| Pubmed | Dystroglycan is a scaffold for extracellular axon guidance decisions. | 5.85e-06 | 6 | 233 | 3 | 30758284 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | EPS8L1 FAT1 DNAJC13 UBR4 ARHGEF12 ATP10A ARFGEF3 CELSR3 ZFHX4 MDC1 ELAVL3 SPEN | 6.72e-06 | 361 | 233 | 12 | 26167880 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MARS1 GAS6 DNAH14 PCNX2 TULP4 PTPRS ABCC8 MKLN1 FNIP1 EHBP1 DPYSL2 DNAJC13 B3GALNT2 FRMPD1 LAMA3 RNF213 CHD9 CEP192 VPS54 ATP10A SNX29 ARFGEF3 NAT10 USP40 TANC1 CSMD1 | 8.78e-06 | 1489 | 233 | 26 | 28611215 |
| Pubmed | 1.03e-05 | 257 | 233 | 10 | 16335952 | ||
| Pubmed | 1.07e-05 | 21 | 233 | 4 | 16079250 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | LRRC70 CSMD2 TMEM132B DNAH14 PARP4 WIZ ALDH16A1 PKD1 UTP20 TICRR DPYSL2 USP22 UBR4 RNF213 ATXN1L RPAP1 CEP295 | 1.12e-05 | 736 | 233 | 17 | 29676528 |
| Pubmed | Tiam1 mediates neurite outgrowth induced by ephrin-B1 and EphA2. | 1.62e-05 | 8 | 233 | 3 | 14988728 | |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 1.62e-05 | 8 | 233 | 3 | 15257293 | |
| Pubmed | TET2 RELN WIZ PTPRD NOMO2 MIB1 PKD1 MKLN1 ARHGAP21 CNTN4 NDST1 DPYSL2 ANK2 SYNE1 UBR4 DVL3 CHD9 VPS54 WDR59 DALRD3 CELSR3 PPT1 TIAM1 | 2.03e-05 | 1285 | 233 | 23 | 35914814 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 2.08e-05 | 170 | 233 | 8 | 23314748 | |
| Pubmed | 2.08e-05 | 83 | 233 | 6 | 11114734 | ||
| Pubmed | ENPP6 ATXN7L2 GAS6 EZH1 FAT1 WIZ EIF4ENIF1 NFRKB ASCC3 USP22 RNASEH2A RNF213 CHD9 C16orf96 ZFHX4 NAT10 CEP295 TANC1 CSMD1 PRDM16 SP140 | 2.29e-05 | 1116 | 233 | 21 | 31753913 | |
| Pubmed | 2.42e-05 | 9 | 233 | 3 | 11403717 | ||
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 2.42e-05 | 9 | 233 | 3 | 36261522 | |
| Pubmed | 2.72e-05 | 87 | 233 | 6 | 12465718 | ||
| Pubmed | TET2 WIZ EIF4ENIF1 ASCC3 ARHGAP21 EHBP1 FLNA DNAJC13 UBR4 DVL3 INPP5F ZFHX4 | 2.87e-05 | 418 | 233 | 12 | 34709266 | |
| Pubmed | TPP2 HCN2 TMEM132B WIZ PTPRD PTPRS EXOG ARHGAP21 CNTN4 DPYSL2 DNAJC13 ANK2 PRR36 SYNE1 UBR4 ARHGEF12 NAT10 ELAVL3 EPHA4 | 3.02e-05 | 963 | 233 | 19 | 28671696 | |
| Pubmed | A2M GLB1 MKLN1 FNIP1 DNAJC13 SLC37A3 DVL3 DALRD3 SNX29 TGFB1 LRRC53 NAT10 USP40 | 3.43e-05 | 496 | 233 | 13 | 31343991 | |
| Pubmed | Isolation of novel mouse genes that were differentially expressed in W/W(V) mouse fundus. | 3.44e-05 | 10 | 233 | 3 | 15065000 | |
| Interaction | FBXO2 interactions | EPHB4 MANBA GAS6 LAMC3 PTPRS ASIC4 DNAJC13 SGSH B3GALNT2 L1CAM ITGA8 LAMA3 NOMO1 TGFB1 LIPA CELSR3 ADAMTS7 CSPG4 NOMO3 | 1.99e-07 | 411 | 225 | 19 | int:FBXO2 |
| Interaction | CEACAM8 interactions | EPHB4 MANBA FAT1 PTPRS MANEAL NDST1 ITGA8 LAMA3 NOMO1 CELSR3 | 9.07e-07 | 119 | 225 | 10 | int:CEACAM8 |
| Interaction | GOLGA1 interactions | FAM91A1 KIAA0753 FNIP1 ASCC3 UBR4 DVL3 ARHGEF12 CEP192 VPS54 ARFGEF3 RPAP1 TANC1 | 1.07e-06 | 183 | 225 | 12 | int:GOLGA1 |
| Interaction | PRG2 interactions | EPHB4 MANBA GAS6 LAMC3 MKLN1 SGSH NOMO1 TGFB1 CELSR1 LIPA ADAMTS7 CSPG4 ADAMTS14 | 2.04e-05 | 285 | 225 | 13 | int:PRG2 |
| Interaction | RYK interactions | EPHB4 PTPRD PTPRS MIB1 CELSR1 CELSR3 EPHA2 CSPG4 PCDH7 NOMO3 EPHA4 | 2.77e-05 | 212 | 225 | 11 | int:RYK |
| Interaction | TRGV3 interactions | 3.33e-05 | 55 | 225 | 6 | int:TRGV3 | |
| Interaction | DKKL1 interactions | 3.51e-05 | 111 | 225 | 8 | int:DKKL1 | |
| Interaction | TOP3B interactions | EPHB4 MYO10 LAMC3 ITGB4 PCNX2 ANOS1 FAT1 WIZ EIF4ENIF1 TULP4 PTPRS MIB1 PKD1 ARHGAP21 FLNA NDST1 SLC37A3 FNTB UBR4 L1CAM CEP192 LRRK1 WDR59 CELSR1 CELSR3 RPAP1 ADAMTS7 CSPG4 MDC1 USP40 DISP2 TANC1 SPEN PRDM16 | 4.06e-05 | 1470 | 225 | 34 | int:TOP3B |
| Cytoband | 3p21.3 | 2.36e-04 | 59 | 233 | 4 | 3p21.3 | |
| Cytoband | 1q21.1 | 2.86e-04 | 62 | 233 | 4 | 1q21.1 | |
| GeneFamily | Fibronectin type III domain containing | EPHB4 ITGB4 FNDC1 ANOS1 PTPRD PTPRS USH2A CNTN4 COL7A1 L1CAM EPHA2 ROS1 TNXB EPHA4 | 3.38e-11 | 160 | 143 | 14 | 555 |
| GeneFamily | Neuroblastoma breakpoint family | 8.66e-07 | 23 | 143 | 5 | 662 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 1.65e-04 | 14 | 143 | 3 | 1095 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 1.85e-04 | 3 | 143 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 1.85e-04 | 3 | 143 | 2 | 1189 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.85e-03 | 66 | 143 | 4 | 722 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.16e-03 | 9 | 143 | 2 | 1234 | |
| Coexpression | GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_DN | IL18R1 ARHGAP31 MIB1 SMOX TECPR1 DPYSL2 FNTB L1CAM CACNA2D4 LIPA LY75 | 1.77e-06 | 200 | 231 | 11 | M7155 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M RELN FAT1 TRANK1 PTPRD USH2A OTOA MGAM PKHD1L1 ARFGEF3 ZFHX4 ROS1 CSMD1 | 1.82e-11 | 184 | 233 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M RELN FAT1 TRANK1 PTPRD USH2A OTOA MGAM PKHD1L1 ARFGEF3 ZFHX4 ROS1 CSMD1 | 1.82e-11 | 184 | 233 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M RELN FAT1 TRANK1 PTPRD USH2A OTOA MGAM PKHD1L1 ARFGEF3 ZFHX4 ROS1 CSMD1 | 1.82e-11 | 184 | 233 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.49e-08 | 182 | 233 | 10 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.98e-08 | 184 | 233 | 10 | 32473dbdb2de66391157c5814ef34e790806e4f2 | |
| ToppCell | 10x5'-Lung-Mast|Lung / Manually curated celltypes from each tissue | 5.80e-08 | 187 | 233 | 10 | f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0 | |
| ToppCell | 10x5'-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue | 5.80e-08 | 187 | 233 | 10 | da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.43e-08 | 192 | 233 | 10 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | SFTA3 DNAH14 ANOS1 SLC19A3 LAMA3 ARFGEF3 CELSR1 ROS1 MAP3K13 PRDM16 | 7.80e-08 | 193 | 233 | 10 | a0ca3231992f14abcf1a6129573bace320e89d2a |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 5.46e-07 | 183 | 233 | 9 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 5.46e-07 | 183 | 233 | 9 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.98e-07 | 185 | 233 | 9 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.98e-07 | 185 | 233 | 9 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.55e-07 | 187 | 233 | 9 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | MYO10 LCN12 NBPF26 ITGB4 ARHGAP31 NBPF14 ZFHX4 NBPF10 PRDM16 | 6.55e-07 | 187 | 233 | 9 | 5c73010fe4c85fb5cc1273f5504821229ca0cc4b |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | MYO10 LCN12 NBPF26 ITGB4 ARHGAP31 NBPF14 ZFHX4 NBPF10 PRDM16 | 6.55e-07 | 187 | 233 | 9 | 5d3d68519c8e19f10c29f9d81712125be78ca15a |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 6.84e-07 | 188 | 233 | 9 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.16e-07 | 189 | 233 | 9 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 8.16e-07 | 192 | 233 | 9 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 8.16e-07 | 192 | 233 | 9 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.16e-07 | 192 | 233 | 9 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | SFTA3 DNAH14 CNTN4 LAMA3 ARFGEF3 CELSR1 TANC1 MAP3K13 PRDM16 | 8.16e-07 | 192 | 233 | 9 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.90e-07 | 194 | 233 | 9 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.28e-07 | 195 | 233 | 9 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.28e-07 | 195 | 233 | 9 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | Neuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.15e-06 | 200 | 233 | 9 | 5ef4a3dc18a44292184a59ced916183c0699b01e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-06 | 155 | 233 | 8 | 29c4e9947bb4f7e257ed5c3bcf21bd67f88d473f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-06 | 164 | 233 | 8 | 2c48c6e4eeee845f0563982d0bfa2a176ca5ef61 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.62e-06 | 165 | 233 | 8 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.62e-06 | 165 | 233 | 8 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.62e-06 | 165 | 233 | 8 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-06 | 172 | 233 | 8 | cc9d9dae290f11f8c348c78228af4e49469dc93b | |
| ToppCell | 3'_v3-GI_small-bowel-Mast-Mast_cell_granulo-myelo|GI_small-bowel / Manually curated celltypes from each tissue | 3.56e-06 | 172 | 233 | 8 | 3df11aefc09762fd1f94441324551178e030b249 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-06 | 172 | 233 | 8 | 3a37569a5902f3c65ff8d3912421309a8c82ee9b | |
| ToppCell | LV-17._Lymphocyte|World / Chamber and Cluster_Paper | 3.72e-06 | 173 | 233 | 8 | 212f013ff761cbab24a537071739867c08c402a4 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.88e-06 | 174 | 233 | 8 | 3503c7dec498597f76a86dbd5e4bb2311e743bde | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-06 | 175 | 233 | 8 | a9f88054e2c28d604c65ed785f63021aadb7f4c8 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-06 | 175 | 233 | 8 | 1b35acece23712ab7e3f92d9d68266efd38b3ef5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.22e-06 | 176 | 233 | 8 | 5914e7635474e7cf24d446bdb1423bc0807ee9c6 | |
| ToppCell | Control-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 4.22e-06 | 176 | 233 | 8 | 0c5916d63e1ada09105e46d2429b75129b7329ec | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 4.22e-06 | 176 | 233 | 8 | d6e660df92a3d7dd5732171ee623763faf108476 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.40e-06 | 177 | 233 | 8 | f1efd9c3074d5635700fe7fbebf3dd0b1e0a84f1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.40e-06 | 177 | 233 | 8 | 85e270b4a0b0da77ffe5987a099e827c02a4adf3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.59e-06 | 178 | 233 | 8 | 2a36475c260088f69f3b8c282d910e5eaa5c5c2d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.59e-06 | 178 | 233 | 8 | 3c973aac16988e88f5677d3d695dd772ccfd6570 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 4.79e-06 | 179 | 233 | 8 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.19e-06 | 181 | 233 | 8 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | LV-17._Lymphocyte|LV / Chamber and Cluster_Paper | 5.19e-06 | 181 | 233 | 8 | 81fafa69c8c240250a667a5f3b321e8be1b9a288 | |
| ToppCell | LA-17._Lymphocyte|LA / Chamber and Cluster_Paper | 5.19e-06 | 181 | 233 | 8 | 3fd9f805fa46141b0fa7023ee5d8688d338635d5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.41e-06 | 182 | 233 | 8 | 3d7a8d2ee2137b098248597058974ef5ae09c19e | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 5.63e-06 | 183 | 233 | 8 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 5.63e-06 | 183 | 233 | 8 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | IPF-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 5.86e-06 | 184 | 233 | 8 | 7326a16d7d3ae41b8c9d2beaec7f977b374f3469 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 6.10e-06 | 185 | 233 | 8 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 6.10e-06 | 185 | 233 | 8 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.10e-06 | 185 | 233 | 8 | bdfa8c284bbc5e85c806327fbb7778cf16242a38 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.34e-06 | 186 | 233 | 8 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-06 | 187 | 233 | 8 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-06 | 187 | 233 | 8 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-06 | 187 | 233 | 8 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-06 | 187 | 233 | 8 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-06 | 187 | 233 | 8 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-06 | 187 | 233 | 8 | 93c78fc7f126132eb84feb47be2c4e8c568b9e91 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.60e-06 | 187 | 233 | 8 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.86e-06 | 188 | 233 | 8 | 6ee3f8f94ea7bdf652c9575fc65bff08070093a4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.86e-06 | 188 | 233 | 8 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | LPS_only-Lymphocytic_NKT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.86e-06 | 188 | 233 | 8 | bbe65b1c11c88ab62d8485cfc3a913ff9da89aad | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 6.86e-06 | 188 | 233 | 8 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-06 | 189 | 233 | 8 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-06 | 189 | 233 | 8 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.13e-06 | 189 | 233 | 8 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | COPD-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 7.13e-06 | 189 | 233 | 8 | 14e8e57e4db336fbef005270647983b4edf407c0 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 7.13e-06 | 189 | 233 | 8 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.13e-06 | 189 | 233 | 8 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 7.41e-06 | 190 | 233 | 8 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.41e-06 | 190 | 233 | 8 | 3b8d1e66ae68c1eee64095e75195d76d97e24026 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.41e-06 | 190 | 233 | 8 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.41e-06 | 190 | 233 | 8 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 7.41e-06 | 190 | 233 | 8 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.41e-06 | 190 | 233 | 8 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.41e-06 | 190 | 233 | 8 | dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.70e-06 | 191 | 233 | 8 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 7.70e-06 | 191 | 233 | 8 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.70e-06 | 191 | 233 | 8 | 468b5149d1533f03521844d3cce8633d44eb6ed4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-06 | 192 | 233 | 8 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-06 | 192 | 233 | 8 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.00e-06 | 192 | 233 | 8 | f6ec683b2133b3095a1fcc06ca8605cf38f774b5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.00e-06 | 192 | 233 | 8 | 690b3d17c481159bc96b8bc7f6a66b51343ee858 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.31e-06 | 193 | 233 | 8 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.31e-06 | 193 | 233 | 8 | 3d3c45d5ff6f3396a1990615aae9fe176e799994 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.63e-06 | 194 | 233 | 8 | 5d0b0d8e96f0e0297a4dba70a05d87081a4eb323 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.63e-06 | 194 | 233 | 8 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.63e-06 | 194 | 233 | 8 | 6ac759828c41ffa974ee82842162caa959351dd1 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.63e-06 | 194 | 233 | 8 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.30e-06 | 196 | 233 | 8 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.30e-06 | 196 | 233 | 8 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 9.65e-06 | 197 | 233 | 8 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.00e-05 | 198 | 233 | 8 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.00e-05 | 198 | 233 | 8 | fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-05 | 199 | 233 | 8 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| Computational | Adhesion molecules. | 5.78e-06 | 141 | 126 | 10 | MODULE_122 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.84e-04 | 50 | 126 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Computational | Genes in the cancer module 85. | 3.12e-04 | 51 | 126 | 5 | MODULE_85 | |
| Computational | Genes in the cancer module 80. | 5.02e-04 | 32 | 126 | 4 | MODULE_80 | |
| Computational | Developmental processes. | RELN ANOS1 KIT FLNA COL7A1 DPYSL2 L1CAM LAMA3 CBLN1 EPHA2 ROS1 EPHA4 | 5.26e-04 | 333 | 126 | 12 | MODULE_220 |
| Drug | atalaphyllidine | 4.04e-06 | 4 | 230 | 3 | CID005479542 | |
| Drug | indolizidine | 4.54e-06 | 25 | 230 | 5 | CID000026136 | |
| Drug | cast 3 | 6.75e-06 | 13 | 230 | 4 | CID000072360 | |
| Disease | Malignant neoplasm of breast | EPHB4 CATSPERE GPR180 PTPRD UTP20 DLEC1 SMOX KIT EHBP1 FLNA COL7A1 ANK2 SYNE1 B3GALNT2 UBR4 FRMPD1 DVL3 DDO KCNT2 MAP3K13 CYB5R4 SPEN | 2.42e-05 | 1074 | 223 | 22 | C0006142 |
| Disease | intellectual disability (implicated_via_orthology) | 2.65e-04 | 75 | 223 | 5 | DOID:1059 (implicated_via_orthology) | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 2.84e-04 | 42 | 223 | 4 | DOID:612 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | TET2 FAT1 PTPRD PTPRS ABCC8 CNTN4 COL7A1 DPYSL2 ANK2 SYNE1 TGFB1 LIG1 RPAP1 TIAM1 HDC | 3.18e-04 | 702 | 223 | 15 | C0009402 |
| Disease | Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease | 3.38e-04 | 4 | 223 | 2 | C1301365 | |
| Disease | Herlitz Disease | 3.38e-04 | 4 | 223 | 2 | C0079683 | |
| Disease | Epidermolysis Bullosa Progressiva | 3.38e-04 | 4 | 223 | 2 | C0079297 | |
| Disease | Gastric Adenocarcinoma | 3.71e-04 | 45 | 223 | 4 | C0278701 | |
| Disease | Salivary Gland Neoplasms | 4.39e-04 | 47 | 223 | 4 | C0036095 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 5.60e-04 | 5 | 223 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 5.60e-04 | 5 | 223 | 2 | C2608084 | |
| Disease | relapsing-remitting multiple sclerosis (is_implicated_in) | 5.60e-04 | 5 | 223 | 2 | DOID:2378 (is_implicated_in) | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 5.60e-04 | 5 | 223 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | Metastatic melanoma | 7.47e-04 | 54 | 223 | 4 | C0278883 | |
| Disease | Junctional Epidermolysis Bullosa | 8.36e-04 | 6 | 223 | 2 | C0079301 | |
| Disease | urate measurement, bone density | HCN2 DNAH14 FNDC1 PTPRD A2ML1 USH2A CNTN4 SYNE1 SNX29 USP40 CYB5R4 ACSM6 TNXB | 9.27e-04 | 619 | 223 | 13 | EFO_0003923, EFO_0004531 |
| Disease | Acute Confusional Senile Dementia | 9.47e-04 | 99 | 223 | 5 | C0546126 | |
| Disease | Alzheimer's Disease, Focal Onset | 9.47e-04 | 99 | 223 | 5 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 9.47e-04 | 99 | 223 | 5 | C0750901 | |
| Disease | Presenile dementia | 9.47e-04 | 99 | 223 | 5 | C0011265 | |
| Disease | Alzheimer Disease, Late Onset | 9.47e-04 | 99 | 223 | 5 | C0494463 | |
| Disease | Familial Alzheimer Disease (FAD) | 9.91e-04 | 100 | 223 | 5 | C0276496 | |
| Disease | Alzheimer's Disease | 1.04e-03 | 101 | 223 | 5 | C0002395 | |
| Disease | azoospermia (implicated_via_orthology) | 1.09e-03 | 27 | 223 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 1.16e-03 | 7 | 223 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | pneumococcal meningitis | 1.55e-03 | 8 | 223 | 2 | EFO_1001114 | |
| Disease | hepatitis A virus cellular receptor 2 measurement | 1.55e-03 | 8 | 223 | 2 | EFO_0008151 | |
| Disease | alpha-2-macroglobulin measurement | 1.55e-03 | 8 | 223 | 2 | EFO_0020138 | |
| Disease | tyrosine-protein kinase receptor TYRO3 measurement | 1.55e-03 | 8 | 223 | 2 | EFO_0020829 | |
| Disease | gallbladder neoplasm | 1.98e-03 | 9 | 223 | 2 | EFO_0004606 | |
| Disease | response to bronchodilator, FEV/FEC ratio | TET2 RIPOR2 TMEM86B TMEM132B FFAR4 PTPRD DLEC1 CNTN4 ARHGEF5 WDR59 KIAA0825 ADAMTS7 PRDM16 PCDH7 | 2.20e-03 | 766 | 223 | 14 | EFO_0004713, GO_0097366 |
| Disease | response to radiation, Abnormality of the urinary system | 2.46e-03 | 10 | 223 | 2 | GO_0009314, HP_0000079 | |
| Disease | heart disease (is_marker_for) | 2.46e-03 | 10 | 223 | 2 | DOID:114 (is_marker_for) | |
| Disease | angina pectoris | 2.65e-03 | 125 | 223 | 5 | EFO_0003913 | |
| Disease | cortical surface area measurement | TET2 RELN LAMC3 SUOX ARHGAP31 PKD1 KIT ARHGAP21 TICRR DPYSL2 DNAJC13 ARHGEF12 CELSR1 KIAA0825 ADAMTS7 MDC1 PCDH7 TNXB PTPN20 EPHA4 | 3.17e-03 | 1345 | 223 | 20 | EFO_0010736 |
| Disease | Glucocorticoid use measurement | 3.18e-03 | 39 | 223 | 3 | EFO_0009942 | |
| Disease | bitter alcoholic beverage consumption measurement | 3.46e-03 | 133 | 223 | 5 | EFO_0010092 | |
| Disease | allergic rhinitis | 3.46e-03 | 133 | 223 | 5 | EFO_0005854 | |
| Disease | body weight | TET2 RELN DNAH14 TULP4 ABCC8 PKD1 FNIP1 PRMT7 KIT DMTF1 EHBP1 MGAM ARHGEF12 POM121L2 CEP192 WDR59 ADAMTS14 PCDH7 EPHA4 | 3.47e-03 | 1261 | 223 | 19 | EFO_0004338 |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 3.57e-03 | 12 | 223 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Thrombocythemia, Essential | 3.57e-03 | 12 | 223 | 2 | C0040028 | |
| Disease | FVC change measurement, response to placebo | 4.20e-03 | 13 | 223 | 2 | EFO_0008344, EFO_0010339 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 4.78e-03 | 45 | 223 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | Malignant neoplasm of salivary gland | 4.78e-03 | 45 | 223 | 3 | C0220636 | |
| Disease | MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K | 4.87e-03 | 14 | 223 | 2 | C1836373 | |
| Disease | oral cavity cancer | 4.87e-03 | 14 | 223 | 2 | EFO_0005570 | |
| Disease | alpha-Dystroglycanopathies | 4.87e-03 | 14 | 223 | 2 | C2936406 | |
| Disease | glycodeoxycholate measurement | 4.87e-03 | 14 | 223 | 2 | EFO_0010493 | |
| Disease | Fukuyama Type Congenital Muscular Dystrophy | 4.87e-03 | 14 | 223 | 2 | C0410174 | |
| Disease | triacylglycerol 52:1 measurement | 4.87e-03 | 14 | 223 | 2 | EFO_0010413 | |
| Disease | Muscle eye brain disease | 4.87e-03 | 14 | 223 | 2 | C0457133 | |
| Disease | Left ventricular noncompaction | 4.87e-03 | 14 | 223 | 2 | C1960469 | |
| Disease | Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies) Type A, 1 | 4.87e-03 | 14 | 223 | 2 | C4284790 | |
| Disease | respiratory system disease | 4.99e-03 | 145 | 223 | 5 | EFO_0000684 | |
| Disease | Acute Promyelocytic Leukemia | 5.09e-03 | 46 | 223 | 3 | C0023487 | |
| Disease | hemorrhoid | 5.29e-03 | 147 | 223 | 5 | EFO_0009552 | |
| Disease | Colorectal Neoplasms | 5.30e-03 | 277 | 223 | 7 | C0009404 | |
| Disease | Walker-Warburg congenital muscular dystrophy | 5.60e-03 | 15 | 223 | 2 | C0265221 | |
| Disease | inherited metabolic disorder (is_implicated_in) | 5.60e-03 | 15 | 223 | 2 | DOID:655 (is_implicated_in) | |
| Disease | Eczema, allergic rhinitis | 6.03e-03 | 215 | 223 | 6 | EFO_0005854, HP_0000964 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.08e-03 | 152 | 223 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Spondyloepiphyseal Dysplasia | 6.36e-03 | 16 | 223 | 2 | C0038015 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 6.36e-03 | 16 | 223 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 6.36e-03 | 16 | 223 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 6.36e-03 | 16 | 223 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 6.36e-03 | 16 | 223 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 6.36e-03 | 16 | 223 | 2 | C0025237 | |
| Disease | Van Buchem disease | 7.18e-03 | 17 | 223 | 2 | C0432272 | |
| Disease | health literacy measurement | 7.56e-03 | 53 | 223 | 3 | EFO_0010104 | |
| Disease | monoclonal gammopathy | 7.56e-03 | 53 | 223 | 3 | EFO_0000203 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DLQPTDVLWSLGDAF | 256 | Q6P461 | |
| TSIFWNDVKDPVSIE | 316 | P55884 | |
| AEGVERPEIVSTWSS | 256 | Q8TC20 | |
| LEYEGTLFTEWSVPE | 41 | Q5SY80 | |
| WVSQDFTLDAPIDSV | 431 | Q5SY80 | |
| WTILAEPGDTIALVF | 236 | Q96PZ7 | |
| FLEISGTEAPSIWLT | 261 | Q96PZ7 | |
| LLQTEPSGDFITIWD | 2226 | Q7Z408 | |
| PAWGTQDEGTLEFTL | 216 | Q6UVK1 | |
| TEGETPSWSLLDLYD | 241 | O95196 | |
| IQASTQEEALAGWEP | 151 | Q8IZ83 | |
| EFIESTAAGTVPWFT | 436 | Q8IZF6 | |
| DGQTIEWIFIDPEAF | 186 | P07510 | |
| EEEEVEFWPGLTSLT | 146 | Q12774 | |
| PWLVQDTEAETLTGF | 356 | Q9UKT5 | |
| WLEVVPEQGIVDLSF | 171 | A8K2U0 | |
| EIAIDVPNVSWSDIG | 616 | Q8NB90 | |
| EEEEVEFWPGLTSLT | 146 | A5YM69 | |
| NSFVWSEIQEEVLPG | 456 | Q8WXK1 | |
| SEIQEEVLPGWTSCV | 461 | Q8WXK1 | |
| DEITDTTAQLSWRPG | 606 | Q8IWV2 | |
| PASLTLWDEEDFQGR | 11 | P53672 | |
| LSPEADESVLWQLFG | 291 | Q14576 | |
| PQLFSGESVVSWSDL | 1691 | Q9NYQ6 | |
| ITIPNAFIGSDVVDW | 436 | Q92997 | |
| PLGNEEVSAVSQAWF | 121 | Q9Y222 | |
| DTLQEGWPTLCFVET | 826 | A7MBM2 | |
| ENIEIIPSEGSSHWA | 196 | Q5T6C5 | |
| SNVDLFTWGTPIVTI | 1196 | O60312 | |
| RLVVPGSSVEWQEDF | 126 | Q8WXS8 | |
| DLQTVAVWGTFLPTT | 1326 | Q9UKP4 | |
| VTVPDTITEWKAGAF | 756 | P01023 | |
| IDQIGEDLLTWFSGP | 861 | Q9NZN5 | |
| LGWSFEPTTVELHVD | 96 | P69849 | |
| FIDPSTLEQQVWATG | 826 | Q86VS3 | |
| SGQEAAVPVTWTEIF | 86 | Q9H3S7 | |
| DQTIESWREEGFPVG | 141 | Q68G75 | |
| APWSLGDFEQLVTSL | 161 | Q9HD47 | |
| VVFDTGSSNLWVPSV | 91 | P0DJD9 | |
| AQWEDITGTTPLTFV | 1271 | Q01484 | |
| QLNTSSAESELWEPG | 26 | P30203 | |
| EVVFGDPTEWTSSVL | 1011 | Q7RTW8 | |
| DPTEWTSSVLQELGT | 1016 | Q7RTW8 | |
| PDSWDSIFGDIERII | 51 | P19113 | |
| WLTVFATDQGVVPLS | 1106 | Q14517 | |
| DGSVTVTIVWDLPEE | 306 | P23352 | |
| TDVEFELIASFWPSL | 311 | Q9H306 | |
| VSGSTWREEELPVSQ | 101 | Q96EL1 | |
| LGWSFEPTTVELHVD | 96 | Q5JPE7 | |
| CVLEFWPVELNDTGS | 81 | Q13478 | |
| SPEFKVLEDAWTVVS | 291 | Q6UB28 | |
| SFQTTGTLDEPWEVL | 736 | Q14676 | |
| PDLWVLERSVDFGST | 166 | Q16787 | |
| PGVQLQTTTDCFEWL | 61 | Q8IV33 | |
| PEIFFDVVSLSTWQE | 46 | Q6P4R8 | |
| ETADLKWVTFPQVDG | 26 | P54760 | |
| PGFVKWTFEILDETN | 61 | P10721 | |
| QESWGEEERNITSFP | 246 | O00214 | |
| GLSDDNIVFPDVTGW | 171 | Q6JVE5 | |
| ESVEFNVWDIGGPAS | 691 | Q38SD2 | |
| IDQWFPALTATESDG | 1141 | Q38SD2 | |
| EPGTSLLAAFDQWRE | 111 | Q16555 | |
| PDAVNFWLGEAAAVT | 161 | P0C870 | |
| LATTWENTGSDVLPF | 876 | A6NM62 | |
| DSSTVVDIQESQWPG | 506 | P0C7T5 | |
| VTWDIDSQFLLGPAF | 1646 | O43451 | |
| TSGATTEADWVPLEL | 711 | Q658Y4 | |
| LTDWTIFPLDTEDAV | 506 | P16278 | |
| SSPEFSAVVSVGDWL | 906 | P54764 | |
| GSVAFWELLTAPLEQ | 251 | Q8IWD5 | |
| IPGEISWDVSFVTLN | 201 | Q5NUL3 | |
| LLETDVSFQPWGSEN | 266 | A6NKB5 | |
| NVTEFIFWGLSQSPE | 6 | Q8NH73 | |
| DFEVSVIGPSQSWVD | 111 | O60245 | |
| RPDFSETGQWDVVTE | 116 | P31512 | |
| ATTVDVFLPGSNEVW | 731 | Q8TET4 | |
| LGWSFEPTTVELHVD | 96 | Q15155 | |
| IAESPEDASQWFSVL | 1291 | Q9HD67 | |
| EKGVLPGEDWTVFQS | 216 | P52848 | |
| PTLFQWSDGTEVTLT | 431 | O60449 | |
| PSVQWLDEDGTTVLQ | 456 | P32004 | |
| TERFEDVWVVSGPLT | 186 | Q9Y2C4 | |
| LPIWRETNETSFEAG | 236 | Q96FT7 | |
| GDVTPETWSSKLFVV | 246 | Q6UVM3 | |
| WDSTPASTGIAVFIV | 281 | Q86V85 | |
| VPWTELLSLQTEDGF | 1571 | Q9UKK3 | |
| IPDTITQWEASGFCV | 746 | Q6IE36 | |
| TQLSWAEPAETNGEI | 1236 | P16144 | |
| ESTEESVEVFWPGTI | 26 | A6NMN3 | |
| VAWETEAGFEPVTRK | 121 | A6NMN3 | |
| IDTPGQIEVFTWSAS | 121 | Q9HCN4 | |
| SDTILEVGWPFSARD | 836 | P53708 | |
| RVSGLEPATVDWAFD | 61 | Q86UY6 | |
| SGDLIPWTVSEQFQD | 601 | Q9H0A0 | |
| GSPLENTETENITFW | 441 | Q7Z2Q7 | |
| VVFDTGSSNLWVPSV | 91 | P0DJD8 | |
| SEEFESQPTGWDVLG | 421 | P78509 | |
| SFESPEEVVVVWDNG | 41 | Q86YT6 | |
| IATQGPLAETTEDFW | 1751 | Q13332 | |
| LVSGWQIFQSTPTEE | 91 | Q99489 | |
| FWAVTAENEPSAGLL | 266 | P04062 | |
| IATQGPLLSTIDDFW | 226 | Q4JDL3 | |
| RNEPVSEKVDIWSFG | 326 | O43283 | |
| VFTELTTDPVELWSA | 371 | Q9UHC9 | |
| LNDSIVDPVDSEWFG | 231 | P50897 | |
| ELFAAIGPEEAWISQ | 791 | Q5K4E3 | |
| SFWDEVLGPTLEETR | 221 | Q3KR16 | |
| DGSWTFAQRPTEQEL | 206 | Q9ULW3 | |
| GFIWDLITPTEDGQT | 1551 | Q3L8U1 | |
| WPVISAFAGDQDVTR | 136 | P23435 | |
| EVFKWLIPDSADTTV | 226 | Q92874 | |
| SEIGSSPLDLWQSVE | 231 | A6NNT2 | |
| IISGDTVIWDNETPI | 146 | P17927 | |
| TEGIPWEVKASISFF | 2976 | Q9UFH2 | |
| ELEAWTTDFALPTTV | 4306 | Q9UFH2 | |
| SRANPTTGSVEWLEE | 6 | Q9NVM4 | |
| AEAGVPAEFSIWTRE | 2251 | P21333 | |
| GIKWTPDENGVITFD | 261 | Q7Z3S7 | |
| ETFGWAPELSTVRLD | 681 | Q5SYB0 | |
| TVVAASWDALPETEG | 376 | Q4ZHG4 | |
| SLENGVFPRWSIEES | 296 | Q8TF40 | |
| SEGVPFRTVSEWLES | 901 | P29317 | |
| PLDVGTESTWEVEVV | 496 | Q14393 | |
| EQFILPESFEGTIVW | 211 | Q8NCR0 | |
| PESFEGTIVWESQDL | 216 | Q8NCR0 | |
| TPWESGNERSLDISI | 491 | Q5TH69 | |
| IFEFTWEELISDPSV | 46 | Q8ND61 | |
| PTETVQTWIELLTGE | 131 | Q9H4A5 | |
| IVASTLSNPELFEEW | 306 | P17174 | |
| IFLGEFDTPEAIWSS | 1191 | O75165 | |
| GPVDTFWVENLNSVL | 1576 | Q0VDD8 | |
| SWVEQIEISPEAFET | 416 | Q8IY82 | |
| KEWTFVIENESPSGR | 96 | Q8NDI1 | |
| TSAVAPFVWLDVGSI | 821 | O00462 | |
| PEIVSITSFNEWHEG | 396 | Q5VSG8 | |
| SWFDIIGLSPDSQED | 71 | O75608 | |
| TTQPVEDERGNVFLW | 61 | Q9NWL6 | |
| SEILSLFSEVQGPWS | 106 | Q9NWL6 | |
| ISDSGINFTDAIWSP | 431 | Q8TEP8 | |
| NLLETSEVGWTSNPE | 1146 | Q8TEP8 | |
| IITPDLFEGTAEWIA | 216 | P49356 | |
| DLAQDPAWTEIFGVL | 351 | Q5D0E6 | |
| ETWDESSGSFLPVPE | 1961 | Q02388 | |
| WDPEGEFIITVGTDQ | 396 | Q6IA86 | |
| DTPFVINSATGWVSV | 696 | Q9NYQ7 | |
| VTPRENELWTSLGDS | 386 | Q8TE68 | |
| VSPLTLVADEGWFIT | 316 | Q6UWR7 | |
| GSFSLQSSIPVWETE | 2376 | Q9C0D2 | |
| AVPELQLSTSWVDFG | 1631 | Q9Y238 | |
| PSVTSFILDTEAVAW | 611 | P18858 | |
| SLTPDNTVGEWQTVF | 446 | Q9NRA2 | |
| LTSAEITNEIFPVWT | 46 | Q9BZV2 | |
| IQDLTEIGTPDVDFW | 216 | Q9Y2H2 | |
| IFEGLLDPSDVTAQW | 116 | Q9Y2B1 | |
| VGITFFKDETTAPWI | 231 | Q9UL51 | |
| WDSLRPTEEGIFQVT | 186 | Q9HBV1 | |
| QDSSIWELSSFEEPG | 486 | Q5SR56 | |
| DTLFSVVALPWLSEG | 891 | P98161 | |
| VVFDTGSSNLWVPSV | 91 | P0DJD7 | |
| ATQGPLAETTEDFWR | 1716 | P23468 | |
| TPLIWASAFGEIETV | 126 | O14593 | |
| WVIDPSELTFVQEIG | 356 | Q08881 | |
| TLSVQGFADSPVSWE | 311 | O75818 | |
| VIIPLATWDFEDSTT | 411 | Q4VX76 | |
| PAGIEEESVLFVWSE | 3906 | O75445 | |
| NFSALWDPVIELISS | 731 | O75691 | |
| TGAFEITLNDVPVWS | 146 | P62341 | |
| VSETIEKDFPVWFGS | 661 | Q7Z5M5 | |
| QTAEVPNLWSVDGEV | 556 | Q8TEQ0 | |
| PNLWSVDGEVTVAEQ | 561 | Q8TEQ0 | |
| TDFVGWALDVLSPNL | 86 | O75792 | |
| IGQFSSIEEEDNPIW | 421 | Q8N4U5 | |
| DVDLTATQSPGVQEW | 6201 | Q8NF91 | |
| GPDWQFDITDLVTEF | 591 | Q14DG7 | |
| VPQESWDEGYSTLSI | 521 | Q3BBV2 | |
| VPQESWDEGYSTLSI | 556 | Q6P3W6 | |
| VPQESWDEGYSTLSI | 556 | Q86T75 | |
| VPQESWDEGYSTLSI | 216 | Q5TI25 | |
| VPQESWDEGYSTLSI | 216 | B4DH59 | |
| SIWYVELSGIDDPDI | 146 | Q9UL63 | |
| TWIIDPIDGTTNFVH | 86 | P29218 | |
| ASPQGDWTVVEVETF | 1331 | Q9H6K5 | |
| FGWEQILTDVEVSPQ | 126 | Q9HAZ2 | |
| SSFEVRTWDPEGVIF | 71 | P04278 | |
| VPSITTDSVFVGRDW | 376 | Q9C0D5 | |
| VVFEWECTGTPALTV | 361 | A6NM43 | |
| VVFEWECTGTPALTV | 361 | Q96SF2 | |
| TEWSVNGSPIDTLRE | 1256 | O95785 | |
| VPGQDILDIWFDSGT | 591 | Q9NSE4 | |
| PWVESEIGYTALSET | 76 | Q06520 | |
| NVSLNFSLWEEEGTP | 726 | P20701 | |
| FNPWLIAESFSEELV | 921 | Q2KHM9 | |
| DVEFVLSAPISEWNG | 451 | Q7L1T6 | |
| VVPERSLGNEQWEFT | 6 | Q9BSU1 | |
| ALEAEPLWATVFGSQ | 351 | P51688 | |
| DTTEVNTDPFPETWL | 366 | Q96KW2 | |
| QSWDGEETVFLPLIV | 246 | Q9Y4F9 | |
| VASLDDFTPSGEWDI | 191 | P17787 | |
| AVFWSSLPDSEIGED | 736 | Q09428 | |
| TSVQWTPETLAAFDL | 361 | Q5VW32 | |
| WFSAGPTSQSETIEL | 221 | Q9NRA8 | |
| ADLIVTTPEKWDGVS | 1421 | Q8N3C0 | |
| IPLVWDFGQLSDVAE | 2576 | Q63HN8 | |
| EISDGLVEISWFFPS | 306 | Q8TCY9 | |
| LESQITCGIWTPDDQ | 166 | Q9NRJ4 | |
| ASLPVNGELWAESET | 1416 | Q86UP3 | |
| GVSTTIDPFWDISLD | 316 | Q9UPT9 | |
| AWQLPSTGDEEVFVS | 1811 | Q7Z2Z1 | |
| SWRQGILSFDLSDPE | 396 | Q7Z392 | |
| TLEDFGSPIWVDRVD | 81 | Q13009 | |
| IEVTAWIGPETESEN | 406 | Q96T58 | |
| PLGDSLSWVASQEDT | 91 | Q9NYP9 | |
| AFNTSVELPVEIWSS | 56 | Q8NCC5 | |
| FNDLSVGGWEITEEP | 191 | Q7Z6L1 | |
| DSPEWLSFDVTGVVR | 191 | P01137 | |
| VSLDSVEPQDWSFGE | 126 | Q8NBB4 | |
| FEDVTLGFTPEEWGL | 16 | Q96GC6 | |
| RWTVPEGEFDSFVIQ | 1081 | P22105 | |
| SWTVPEGEFDSFVVQ | 1596 | P22105 | |
| DSLSLSWTVPEGQFD | 2001 | P22105 | |
| PVEWTGAEESLFRVF | 431 | Q92800 | |
| EVSLSAFGEWTEIPG | 216 | Q9NWM0 | |
| GESPLDSLAETFWET | 1156 | P29144 | |
| TLTVVPEEEIQEGFW | 106 | Q6UXR4 | |
| VGDDFWIPETSFILT | 1851 | P08922 | |
| LSDGVLAWDTFAQPL | 181 | Q8N661 | |
| QWEDLTPLTFGVQEL | 281 | Q15904 | |
| ELAENTWVTPEGVTL | 1391 | Q2M1Z3 | |
| SLLNDDVTPAAFWVT | 2551 | Q86WI1 | |
| TNQWAVTDPEDVLVG | 126 | A8MWL6 | |
| VAPGDEELLDSTFSW | 471 | Q9BWH6 | |
| GVWSPDIEQSFQEAL | 41 | Q15561 | |
| VFTPEEWVFLDSTQR | 211 | Q96JL9 | |
| LDWAVFEPDLLVTSS | 111 | Q6PJI9 | |
| TEWLQLSGFENPVSE | 26 | P0C7M3 | |
| QTEDGKWFTPTEFEI | 616 | Q13342 | |
| PETGIWVTLGSEVFD | 96 | P51687 | |
| DFTDIVPGVSTLFSW | 136 | Q6UX68 | |
| IFTTGFPTEVWQSVI | 116 | O15050 | |
| DSEPILGQWFEETIS | 586 | Q5T4S7 | |
| DWFFTEEGAEEPLTT | 1336 | Q5T5U3 | |
| VWSDSEQSFLDPDIG | 1846 | Q6N021 | |
| PVVSQTESVWDLTFD | 546 | Q9NVE5 | |
| PEGQDSAFSWTDLLL | 626 | P56192 | |
| VWSLTGQVAEDRFPE | 311 | Q9H808 | |
| TKTWGLDFVDTEVIP | 91 | Q9P1Q0 | |
| ISIDFTQEEWGQLAP | 81 | Q49AA0 | |
| ESPGLQEWVTSTELL | 221 | Q9Y6N6 | |
| NVSEIISYWGFPSEE | 36 | P38571 |